Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (331-340 of 477) with videos related to

Pageof 48
Sort By:
Cancer Science|March 21, 2012
Expression of a splicing variant of the CADM1 specific to small cell lung cancerShinji Kikuchi, Miwako Iwai, Mika Sakurai-Yageta, et al.
Cancer Science|May 3, 2008
Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinomaErina Nakamura, Ken-ichi Kozaki, Hitoshi Tsuda, et al.
Acta Medica Okayama|June 28, 2013
p53 expression in pretreatment specimen predicts response to neoadjuvant chemotherapy including anthracycline and taxane in patients with primary breast cancerTadahiko Shien, Takayuki Kinoshita, Kunihiko Seki, et al.
Hormones & Cancer|September 9, 2011
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancerTakashi Shigekawa, Nobuhiro Ijichi, Kazuhiro Ikeda, et al.
Molecular Cancer Research : MCR|June 19, 2014
Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasisTakamasa Uekita, Satoko Fujii, Yuri Miyazawa, et al.
Breast Cancer (Tokyo, Japan)|December 13, 2018
Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40-44 yearsAi Hironaka-Mitsuhashi, Hitoshi Tsuda, Masayuki Yoshida, et al.
Annals of Surgical Oncology|July 7, 2018
Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node MetastasisKenzo Shimazu, Nobuaki Sato, Akiko Ogiya, et al.
The American Journal of Surgical Pathology|February 22, 2013
Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapyAkiko M Maeshima, Hirokazu Taniguchi, Suguru Fukuhara, et al.
International Journal of Hematology|October 14, 2017
TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation modelAyako Kobayashi, Shinichi Kobayashi, Kosuke Miyai, et al.
Japanese Journal of Clinical Oncology|June 23, 2012
Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumourDaisuke Kubota, Taketo Okubo, Tsuyoshi Saito, et al.
Pageof 48

Showing results (331-340 of 477) with videos related to

Sort By:
Pageof 48
Cancer Science|March 21, 2012
Expression of a splicing variant of the CADM1 specific to small cell lung cancerShinji Kikuchi, Miwako Iwai, Mika Sakurai-Yageta, et al.
Cancer Science|May 3, 2008
Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinomaErina Nakamura, Ken-ichi Kozaki, Hitoshi Tsuda, et al.
Acta Medica Okayama|June 28, 2013
p53 expression in pretreatment specimen predicts response to neoadjuvant chemotherapy including anthracycline and taxane in patients with primary breast cancerTadahiko Shien, Takayuki Kinoshita, Kunihiko Seki, et al.
Hormones & Cancer|September 9, 2011
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancerTakashi Shigekawa, Nobuhiro Ijichi, Kazuhiro Ikeda, et al.
Molecular Cancer Research : MCR|June 19, 2014
Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasisTakamasa Uekita, Satoko Fujii, Yuri Miyazawa, et al.
Breast Cancer (Tokyo, Japan)|December 13, 2018
Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40-44 yearsAi Hironaka-Mitsuhashi, Hitoshi Tsuda, Masayuki Yoshida, et al.
Annals of Surgical Oncology|July 7, 2018
Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node MetastasisKenzo Shimazu, Nobuaki Sato, Akiko Ogiya, et al.
The American Journal of Surgical Pathology|February 22, 2013
Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapyAkiko M Maeshima, Hirokazu Taniguchi, Suguru Fukuhara, et al.
International Journal of Hematology|October 14, 2017
TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation modelAyako Kobayashi, Shinichi Kobayashi, Kosuke Miyai, et al.
Japanese Journal of Clinical Oncology|June 23, 2012
Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumourDaisuke Kubota, Taketo Okubo, Tsuyoshi Saito, et al.
Pageof 48